Patient Education Ecosystem

Asthma is a chronic inflammatory disorder of the airways characterized by hyper-responsiveness, reversible airflow limitation, and bronchospasm loops. Mucosal edema and increased mucus production trigger severe dyspnea and classic paroxysmal coughing or wheezing cycles.

Effective management separates long-term anti-inflammatory controller medications (Inhaled Corticosteroids) from emergency short-acting bronchodilators (SABA inhalers). Systemic triggers require absolute compliance mitigation profiles.

Brethezy introduces advanced fractional exhaled nitric oxide (FeNO) mapping and precise digital spirometry screening metrics alongside custom monoclonal antibody therapies to completely arrest severe cascades.

Obstructive Sleep Apnea involves micro-collapses of pharyngeal soft tissue layers during muscle tone drops inside deeper REM states, yielding severe arterial hypoxemia spikes, chronic micro-arousals, and systemic sympathetic overdrive loops.

Continuous Positive Airway Pressure (CPAP) arrays establish a robust air column column splint inside target pathways, neutralizing hypopnea episodes, lowering daytime somnolence, and stabilizing long-term systemic cardiovascular risks.

Our clinics provide luxury, diagnostic overnight telemetry centers executing multi-channel polysomnography. This allows our clinical team to fine-tune smart auto-adjusting BiPAP systems and construct specialized retaining splints.